American International Group’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-569
| Closed | -$180K | – | 3024 |
|
|
2023
Q4 | $180K | Sell |
569
-15
| -3% | -$2.92K | ﹤0.01% | 2225 |
|
|
2023
Q3 | $98.7K | Sell |
584
-41
| -7% | -$7.71K | ﹤0.01% | 2521 |
|
|
2023
Q2 | $136K | Sell |
625
-15,018
| -96% | -$3.22M | ﹤0.01% | 2396 |
|
|
2023
Q1 | $2.84M | Buy |
15,643
+1,344
| +9% | +$257K | 0.02% | 874 |
|
|
2022
Q4 | $2.81M | Buy |
14,299
+123
| +0.9% | +$26.4K | 0.02% | 861 |
|
|
2022
Q3 | $3.19M | Buy |
14,176
+1,872
| +15% | +$379K | 0.02% | 830 |
|
|
2022
Q2 | $1.56M | Buy |
12,304
+1,280
| +12% | +$147K | 0.01% | 1025 |
|
|
2022
Q1 | $1.4M | Sell |
11,024
-775
| -7% | -$87.3K | 0.01% | 1165 |
|
|
2021
Q4 | $1.55M | Sell |
11,799
-353
| -3% | -$45.6K | 0.01% | 1189 |
|
|
2021
Q3 | $1.49M | Sell |
12,152
-289
| -2% | -$33.4K | 0.01% | 1195 |
|
|
2021
Q2 | $1.42K | Buy |
12,441
+3,233
| +35% | +$378K | ﹤0.01% | 1322 |
|
|
2021
Q1 | $1.11K | Buy |
9,208
+25
| +0.3% | +$2.83K | ﹤0.01% | 1406 |
|
|
2020
Q4 | $933 | Sell |
9,183
-263
| -3% | -$24.4K | ﹤0.01% | 1428 |
|
|
2020
Q3 | $730K | Sell |
9,446
-38
| -0.4% | -$3.24K | ﹤0.01% | 1403 |
|
|
2020
Q2 | $1.06M | Buy |
9,484
+3,270
| +53% | +$284K | 0.01% | 1197 |
|
|
2020
Q1 | $447K | Buy |
6,214
+3,347
| +117% | +$286K | ﹤0.01% | 1488 |
|
|
2019
Q4 | $216K | Sell |
2,867
-25
| -0.9% | -$1.09K | ﹤0.01% | 2168 |
|
|
2019
Q3 | $47K | Buy |
+2,892
| New | +$56.2K | ﹤0.01% | 2900 |
|
Other funds holding KRTX
American International Group's KRTX Position: Q1 2024 in Review
American International Group sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 569 shares — an estimated $180K sold.
American International Group first reported a position in KRTX in Q3 2019 and held it in 18 quarters. The position peaked at $3.19M in Q3 2022. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.
- American International Group reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- American International Group sold 569 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $180K.
- American International Group first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2019 and held it in 18 quarters.
- American International Group's Karuna Therapeutics, Inc. Common Stock position peaked at $3.19M in Q3 2022.
- 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.
Based on American International Group's 13F filing for Q1 2024, filed 13 May 2024.